Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2083104 | Drug Discovery Today: Therapeutic Strategies | 2006 | 7 Pages |
Abstract
Adenosine, a ubiquitous biological molecule elicits both pro- and anti-inflammatory effects in the lungs. Bronchoconstriction in subjects with asthma after adenosine inhalation involves a selective interaction with adenosine receptors, which is subsequently linked to the release of mast cell mediators. Animal studies also support a role for adenosine in inflammation and airway hyperresponsiveness. Therefore, selective blockade of adenosine receptors may be an attractive and valuable approach to the treatment of asthma.
Section editors:Roy Goldie – Faculty of Health Sciences, Flinders University, Adelaide, AustraliaPeter Henry – School of Medicine & Pharmacology, The University of Western Australia, Nedlands, Australia
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Ahmed Nadeem, S. Jamal Mustafa,